Indeed, large-scale sequencing efforts encompassing thousands of CRC specimens have not identified JAK2 p.V617F mutations in tumor tissue, suggesting that this alteration is exceedingly rare or potentially absent from primary colorectal carcinogenesis (Herreros-Villanueva et al., 2010; Strickler et al., 2018). Here, JAK2 is linked to colorectal carcinoma.